These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19466518)

  • 1. Matrix metalloproteinase-1 and -2 levels are differently regulated in acute exacerbation of heart failure in patients with and without left ventricular systolic dysfunction.
    Naito Y; Tsujino T; Lee-Kawabata M; Matsumoto M; Ezumi A; Nakao S; Goda A; Ohyanagi M; Masuyama T
    Heart Vessels; 2009 May; 24(3):181-6. PubMed ID: 19466518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.
    Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T
    Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
    Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H
    J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.
    Kitzman DW; Little WC; Brubaker PH; Anderson RT; Hundley WG; Marburger CT; Brosnihan B; Morgan TM; Stewart KP
    JAMA; 2002 Nov; 288(17):2144-50. PubMed ID: 12413374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure.
    Bruch C; Gradaus R; Gunia S; Breithardt G; Wichter T
    J Am Soc Echocardiogr; 2003 Oct; 16(10):1031-6. PubMed ID: 14566295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure.
    Watanabe S; Shite J; Takaoka H; Shinke T; Imuro Y; Ozawa T; Otake H; Matsumoto D; Ogasawara D; Paredes OL; Yokoyama M
    Eur Heart J; 2006 Apr; 27(7):832-8. PubMed ID: 16464912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focale: study of systolic and diastolic heart failure in a French elderly population.
    Dubourg O; Gueret P; Beauchet A; Nisse-Durgeat S; Ducardonnet A
    Int J Cardiol; 2008 Feb; 124(2):188-92. PubMed ID: 17399824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
    Troughton RW; Prior DL; Pereira JJ; Martin M; Fogarty A; Morehead A; Yandle TG; Richards AM; Starling RC; Young JB; Thomas JD; Klein AL
    J Am Coll Cardiol; 2004 Feb; 43(3):416-22. PubMed ID: 15013124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction.
    Yu CM; Lin H; Yang H; Kong SL; Zhang Q; Lee SW
    Circulation; 2002 Mar; 105(10):1195-201. PubMed ID: 11889013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
    Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
    J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
    Zile MR; Bennett TD; St John Sutton M; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Stevenson LW; Kueffer FJ; Bourge RC
    Circulation; 2008 Sep; 118(14):1433-41. PubMed ID: 18794390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure.
    Zareba KM; Shenkman HJ; Bisognano JD
    Congest Heart Fail; 2009; 15(4):165-9. PubMed ID: 19627289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial structure and function differ in systolic and diastolic heart failure.
    van Heerebeek L; Borbély A; Niessen HW; Bronzwaer JG; van der Velden J; Stienen GJ; Linke WA; Laarman GJ; Paulus WJ
    Circulation; 2006 Apr; 113(16):1966-73. PubMed ID: 16618817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure.
    Nakao S; Goda A; Yuba M; Otsuka M; Matsumoto M; Yoshida C; Ohyanagi M; Naito Y; Lee M; Tsujino T; Masuyama T
    Circ J; 2007 Sep; 71(9):1412-7. PubMed ID: 17721020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
    Squire IB; Evans J; Ng LL; Loftus IM; Thompson MM
    J Card Fail; 2004 Aug; 10(4):328-33. PubMed ID: 15309700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.